NJ Law Amends the New Jersey Law Against Discrimination
Client Alert | 1 min read | 05.02.18
On April 24, 2018, Governor Phil Murphy signed New Jersey’s equal pay legislation into law. The legislation, known as the Diane B. Allen Equal Pay Act, amends the New Jersey Law Against Discrimination and expands the categories of individuals who are protected from pay discrimination and imposes stringent requirements and penalties against employers who are found to violate the law.
The New Jersey law is notable and different from laws enacted recently by other states because it prohibits unlawful discrimination in pay or benefits on the basis of membership in any protected class, including those based on race, creed, color, national origin, ancestry, age, marital status, civil union status, domestic partnership status, affectional or sexual orientation, genetic information, pregnancy, sex, gender identity or expression, disability or atypical hereditary cellular or blood trait of any individual, or liability for service in the armed forces. It also requires that employees receive equal compensation for “substantially similar” work – supplementing in New Jersey the federal requirement that employees be paid the same for “equal work.” Other key provisions include the following:
- Employers may not prohibit employees from discussing their pay with others or retaliate against those who do so.
- Claimants are entitled to treble damages upon a jury finding of discriminatory compensation.
- Back pay awards may look back six years.
The law takes effect on July 1, 2018. With the implementation of this law, New Jersey joins at least seventeen states – including New York, California, and Pennsylvania – and many localities that have recently amended equal pay laws to make them more employee-friendly. This latest development further underscores the need for employers to conduct a privileged, holistic review of their compensation systems, including privileged analyses of compensation, to ensure compliance with the laws of the jurisdictions in which they operate.
Contacts
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26
Client Alert | 3 min read | 06.24.26



